TAU-FLUVALINATE; - Rezultatele cautarii

astrazeneca ab - osimertinib mesilate - carcinom, pulmonar non-celulă mică - alte medicamente antineoplazice, inhibitori de proteinkinază - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sotagamma 80 mg

artesan pharma gmbh & co. kg - germania - sotalolum - compr. - 80mg - medicamente betablocante betablocante neselective

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

octagam 10%

octapharma pharmazeutika produktionsges m.b.h. - austria - imunoglobulina normala pt. adm. intravasculara - sol. perf. - 100 mg/ml - imunoglobuline imunoglobulina umana de origine umana